Highlights Deciphera Pharmaceuticals, Inc.

Equities

DCPH

US24344T1016

Market Closed - Nasdaq Other stock markets 04:00:01 2024-05-31 pm EDT			5-day change	1st Jan Change
25.54 ^USD	+0.04%		+0.12%	+58.34%

May. 10	Deciphera Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
May. 01	North American Morning Briefing : Traders Wait for -2-	DJ

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Deciphera Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 10	CI
North American Morning Briefing : Traders Wait for -2-	May. 01	DJ
North American Morning Briefing : More Earnings -2-	Apr. 30	DJ
Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion	Apr. 30	RE
US Equity Markets Close Higher Monday Ahead of Earnings, Fed Meeting This Week	Apr. 29	MT
Sector Update: Health Care Stocks Edge Higher Late Afternoon	Apr. 29	MT
Top Midday Gainers	Apr. 29	MT
Sector Update: Health Care Stocks Rise in Monday Afternoon Trading	Apr. 29	MT
Sector Update: Health Care	Apr. 29	MT
Deciphera Agrees to $2.4 Billion Buyout Offer From Japan's ONO Pharmaceutical	Apr. 29	MT
Deciphera Shares Hit 2-Year High After $2.4 Billion Buyout Offer From ONO Pharma	Apr. 29	DJ
Deciphera Pharmaceuticals to Be Acquired by ONO Pharmaceutical in $2.4 Billion Deal	Apr. 29	MT
Sector Update: Health Care	Apr. 29	MT
Deciphera Pharmaceuticals to Be Acquired by ONO Pharmaceutical in $2.4 Billion Deal	Apr. 29	MT
Deciphera Pharmaceuticals Gets $2.4 Billion Buyout Offer From ONO Pharmaceutical	Apr. 29	DJ
Deciphera Pharmaceuticals to Be Acquired by ONO Pharmaceutical in $2.4 Billion Deal	Apr. 29	MT
Japan's Ono Pharmaceutical to buy Deciphera for $2.4 billion	Apr. 29	RE
Ono Pharmaceutical Co., Ltd. entered into a definitive merger agreement to acquire Deciphera Pharmaceuticals, Inc. for $2.2 billion.	Apr. 28	CI
Deciphera Pharmaceuticals' Q4 Net Loss Narrows, Revenue Rises	Feb. 06	MT
Earnings Flash (DCPH) DECIPHERA PHARMACEUTICALS Posts Q4 Revenue $48.3M, vs. Street Est of $46.8M	Feb. 06	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Deciphera Pharmaceuticals, Inc.

Equities

DCPH

US24344T1016

Highlights

Filters